Crispr-based Ocular Therapy

CRISPR-Based Ocular Therapy is a gene-editing intervention that employs CRISPR-Cas systems to precisely modify genetic sequences within ocular tissues for the treatment of inherited or acquired eye disorders.

32

Publications

3.1K

Citations

251

Authors

83

Institutions

Publications per year

2017–2026

28

Authors

251

  1. TJ
    Thomas J. Corydon

    Aarhus University, Denmark

    3 publications · 121 citations

    3

    h-index

  2. RR
    Robin R. Ali

    University College London, United Kingdom

    3 publications · 147 citations

    3

    h-index

  3. AL
    Anne Louise Askou

    Aarhus University, Denmark

    3 publications · 121 citations

    3

    h-index

  4. DK
    Daesik Kim

    Seoul National University, South Korea

    2 publications · 267 citations

    2

    h-index

  5. JH
    Jin Hyoung Kim

    Seoul National University Hospital, South Korea

    2 publications · 267 citations

    2

    h-index

1–5 of 251

Venues

  1. Gene Therapy

    4 publications · 105 citations

    4

    h-index

  2. Methods in molecular biology

    Book series · 2 publications · 31 citations

    2

    h-index

  3. Molecular Therapy

    2 publications · 127 citations

    2

    h-index

  4. Investigative Ophthalmology & Visual Science

    IOVS · 2 publications · 38 citations

    2

    h-index

  5. Scientific Reports

    2 publications · 41 citations

    2

    h-index

1–5